Literature DB >> 15367722

The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades.

Harry Björkbacka1, Katherine A Fitzgerald, François Huet, Xiaoman Li, James A Gregory, Melinda A Lee, Christine M Ordija, Nicole E Dowley, Douglas T Golenbock, Mason W Freeman.   

Abstract

Myeloid differentiation protein-88 (MyD88) is a signal adaptor protein required for cytokine production following engagement of Toll-like receptors (TLRs) by their cognate ligands. Activation of both TLR-3 and TLR-4, however, can engage signaling events independent of MyD88 expression. The relative importance of these MyD88-dependent and -independent signaling pathways in the macrophage response to lipopolysaccharide (LPS) is unknown. Here we define these events using microarray expression profiling of LPS-stimulated macrophages taken from MyD88-null and wild-type mice. Of the 1,055 genes found to be LPS responsive, only 21.5% were dependent on MyD88 expression, with MyD88-independent genes constituting 74.7% of the genetic response. This MyD88-independent gene expression was predominantly transcriptionally regulated, as it was unaffected by cycloheximide blockade of new protein synthesis. A previously undescribed group of LPS-regulated genes (3.8%), whose induction or repression was significantly greater in the absence of MyD88, was also identified by these studies. The regulation of these genes suggested that MyD88 could serve as a molecular brake, constraining gene activity in a subset of LPS-responsive genes. The findings generated with LPS stimulation were recapitulated by exposure of macrophages to live Escherichia coli. These expression-profiling studies redefine the current dogma of TLR-4 signaling and establish that MyD88, although essential for some of the best-characterized macrophage responses to LPS, is not required for the regulation of the majority of genes engaged by macrophage exposure to endotoxin or live bacteria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367722     DOI: 10.1152/physiolgenomics.00128.2004

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  86 in total

1.  High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.

Authors:  Masashi Suzuki; David K Pritchard; Lev Becker; Andrew N Hoofnagle; Natsuko Tanimura; Theo K Bammler; Richard P Beyer; Roger Bumgarner; Tomas Vaisar; Maria C de Beer; Frederick C de Beer; Kensuke Miyake; John F Oram; Jay W Heinecke
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

2.  Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure.

Authors:  Palash Mandal; Sanjoy Roychowdhury; Pil-Hoon Park; Brian T Pratt; Thierry Roger; Laura E Nagy
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

3.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

4.  Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus.

Authors:  Hyun A Yoon; Seong Kug Eo
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

5.  VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genes.

Authors:  Ruben Papoian; Andreas Scherer; Muriel Saulnier; Frank Staedtler; André Cordier; Francois Legay; Gerard Maurer; Joerg Staeheli; Jacky Vonderscher; Salah-Dine Chibout
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 6.  Role of Toll-like receptors in infection and immunity: clinical implications.

Authors:  Patricia Cristofaro; Steven M Opal
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 7.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

8.  TLR4/MyD88/PI3K interactions regulate TLR4 signaling.

Authors:  Michelle H W Laird; Sang Hoon Rhee; Darren J Perkins; Andrei E Medvedev; Wenji Piao; Matthew J Fenton; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-03-16       Impact factor: 4.962

9.  Lipopolysaccharide Upregulates Palmitoylated Enzymes of the Phosphatidylinositol Cycle: An Insight from Proteomic Studies.

Authors:  Justyna Sobocińska; Paula Roszczenko-Jasińska; Monika Zaręba-Kozioł; Aneta Hromada-Judycka; Orest V Matveichuk; Gabriela Traczyk; Katarzyna Łukasiuk; Katarzyna Kwiatkowska
Journal:  Mol Cell Proteomics       Date:  2017-12-07       Impact factor: 5.911

Review 10.  Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.

Authors:  C R Casella; T C Mitchell
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.